Target intelligence / Profile preview

Novel transcript, antisense to Musashi-2

Molecular classification: Other

Overview

The "novel transcript, antisense to MSI2" (ENSG00000286732) represents a noncoding RNA mapped antisense to the MSI2 gene locus. It does not encode a functional protein and is not established as a therapeutic target. The MSI2 gene itself encodes Musashi-2, an RNA-binding protein implicated in posttranscriptional gene regulation and cancer biology, but the antisense transcript remains poorly annotated and functionally uncharacterized in current biomedical literature[5][1].

Other names: ENSG00000286732

Beyond the preview

Go deeper on Novel transcript, antisense to Musashi-2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to Musashi-2.

Explore the full profile